Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Wolfe

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Journal of the American College of Cardiology|April 1, 1990
Silent myocardial ischemia: its impact on prognosisC L Wolfe
Cardiology Clinics|August 1, 1989
Assessment of myocardial ischemia and infarction by contrast enhanced magnetic resonance imagingC L Wolfe
The Western Journal of Medicine|November 1, 1989
Thrombolytic therapy for acute myocardial infarctionC L Wolfe
Management Review|February 10, 1983
Crisis in data processing productivity...how to solve the information backlogC L Wolfe, D P Vondle
Postgraduate Medicine|September 23, 1997
Acute myocardial infarction. Recommendations for medical management and primary angioplastyB K Whisenant, C L Wolfe
Cardiology Clinics|February 1, 1994
Nonglycoside inotropes in congestive heart failure. Are they beneficial or harmful?K Chatterjee, C L Wolfe, T DeMarco
American Heart Journal|May 1, 1992
Adult respiratory distress syndrome following thrombolytic therapy with APSAC for acute myocardial infarctionS P Le, K Chatterjee, C L Wolfe
Journal of Cardiovascular Pharmacology|January 1, 1994
Reduction of infarct size during myocardial ischemia and reperfusion by lazaroid U-74500A, a nonglucocorticoid 21-aminosteroidM A Levitt, R E Sievers, C L Wolfe
The Journal of Biological Chemistry|March 1, 1996
Mechanisms leading to and the consequences of altering the normal distribution of ATP(CTP):tRNA nucleotidyltransferase in yeastC L Wolfe, A K Hopper, N C Martin
Postgraduate Medicine|December 1, 1994
Thrombolysis after acute myocardial infarction. Who should be added to inclusion criteria?V M Figueredo, T M Amidon, C L Wolfe
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Journal of the American College of Cardiology|April 1, 1990
Silent myocardial ischemia: its impact on prognosisC L Wolfe
Cardiology Clinics|August 1, 1989
Assessment of myocardial ischemia and infarction by contrast enhanced magnetic resonance imagingC L Wolfe
The Western Journal of Medicine|November 1, 1989
Thrombolytic therapy for acute myocardial infarctionC L Wolfe
Management Review|February 10, 1983
Crisis in data processing productivity...how to solve the information backlogC L Wolfe, D P Vondle
Postgraduate Medicine|September 23, 1997
Acute myocardial infarction. Recommendations for medical management and primary angioplastyB K Whisenant, C L Wolfe
Cardiology Clinics|February 1, 1994
Nonglycoside inotropes in congestive heart failure. Are they beneficial or harmful?K Chatterjee, C L Wolfe, T DeMarco
American Heart Journal|May 1, 1992
Adult respiratory distress syndrome following thrombolytic therapy with APSAC for acute myocardial infarctionS P Le, K Chatterjee, C L Wolfe
Journal of Cardiovascular Pharmacology|January 1, 1994
Reduction of infarct size during myocardial ischemia and reperfusion by lazaroid U-74500A, a nonglucocorticoid 21-aminosteroidM A Levitt, R E Sievers, C L Wolfe
The Journal of Biological Chemistry|March 1, 1996
Mechanisms leading to and the consequences of altering the normal distribution of ATP(CTP):tRNA nucleotidyltransferase in yeastC L Wolfe, A K Hopper, N C Martin
Postgraduate Medicine|December 1, 1994
Thrombolysis after acute myocardial infarction. Who should be added to inclusion criteria?V M Figueredo, T M Amidon, C L Wolfe
Pageof 6